Skip to main content

Table 3 Comparison with other studies which evaluate the out-of-hospital impact of changes in a hospital drug formulary

From: Impact of a change of bronchodilator medications in a hospital drug formulary on intra- and out-of-hospital drug prescriptions: interrupted time series design with comparison group

Author/year

Country

Setting

Therapeutic group

Methodology

Pre-/post-intervention period

Other contextual factors

Effect

Vázquez-Mourelle et al./2017 [16]

Spain

Public district hospital

PPIs

Interrupted time series analysis

1 January 2013/31 December 2015 (36 months)

Inclusion of omeprazole

None

Immediate reduction in pantoprazole in hospital outpatient clinics and long-term reduction in primary care. Sharp and long-term rise in the percentage of omeprazole over total PPIs in hospital out-patient units and primary care respectively.

Vázquez-Mourelle et al./2019 [17]

Spain

Public tertiary university teaching hospital

LMWH

Interrupted time series analysis with control group

1 January 2011/31 December 2016 (72 months)

Withdrawal of bemiparin and dalteparin

Restriction on use of tinzaparin

Maintenance of enoxaparin

None

Immediate significant reduction of 55.6% in the medication that was withdrawn and a 9.0% reduction in the medication that was restricted. Immediate 32.6% increase in the drug retained as freely prescribable.

Gallini et al./2013 [14]

France

National health system

Serotonin antagonists

LMWH

EPO

PPIs

ACE inhibitors

ARBs

Statins

AAAs

SSRIs

Ecological study of spatial clusters, analysed by multivariate linear regression with instrumental variables.

NA (cross sectional)

None

Positive influence of hospital-prescribed medications on community prescriptions. This influence varied, both with drug class, proving stronger in the classes used for the cardiovascular system, and with hospital size.

Larsen et al./2014 [15]

Denmark

Public tertiary university teaching hospital

PPIs (policy of replacing an expensive PPI (esomeprazole) with less expensive PPIs)

Pre-post, descriptive statistics in exact numbers and percentages

1 January 2009/31 December 2010 (policy change: switch to using a less expensive PPI)

Esomeprazole was offered to hospital with a 90% discount, which was an expensive PPI out-of-hospital.

The probability of having an expensive PPI after hospitalisation decreased from 13.4 to 6.5%, while use of recommended PPIs increased.

  1. LMWH low molecular weight heparins, EPO erythropoietin, PPIs proton pump inhibitors, ACE inhibitors angiotensin-converting enzyme antagonists inhibitors, ARBs angiotensin-receptor blockers, AAAs alpha-adrenoreceptor antagonists, SSRIs selective serotonin re-uptake inhibitors